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Background: Hepatitis C, caused by hepatitis C virus (HCV) is a contagious disease of the liver which infects more
than 170 million people world-wide and around 16 million in Pakistan. HCV associated infection spreads mainly by
blood-to-blood contact. In recent years, many studies have been conducted to determine the prevalence of HCV
infection in Pakistan; however, no data is available on HCV infection from the largest province of Pakistan.
Therefore, the present study focuses on the prevalence of HCV infection in the young male blood donor
population of Quetta region of Balochistan, Pakistan.
Methods: A total of 356 blood samples were collected from blood donors (age range 17–25 years) at Combined
Military Hospital (CMH), Quetta, Balochistan, Pakistan. Blood samples were screened for HCV positivity by
Immunochromatographic test (ICT) and Enzyme Linked Immunosorbant Assay (ELISA).
Results: Out of 356 blood samples, the overall HCV prevalence was 20.8%. Among the HCV positive cases, the age
group with 25 years was more frequently infected with a prevalence of 26.3%.
Conclusions: The present study provides the preliminary information about high HCV prevalence among the
young male donor population in Balochistan province. This data may be helpful in formulating public health
strategy for the prevention of risk factors associated with spreading of the disease. Furthermore, we recommend
that in public sector hospitals and health care units ELISA should be preferred for anti-HCV detection over ICT.
Keywords: Enzyme linked immunosorbant assay, Hepatitis C virus, Immunochromatography, Quetta, PakistanBackground
Hepatitis C is an infectious disease caused by the hepa-
titis C virus (HCV) primarily affecting the liver [1]. HCV
has a single-stranded RNA genome and belongs to
Hepacivirus [2]. Infected blood, blood products and
body fluid are some major risk factors for HCV trans-
mission. Furthermore, use of contaminated syringes,
drug abuse, and use of barber razor, dental procedures,
tattooing, ear piercing, acupuncture and high-risk sexual
behavior are other modes of transmission [3]. In more
than 70% of the infected people, the disease becomes
chronic and leads to chronic hepatitis, 5-20% develops
cirrhosis, and 1–5% died from cirrhosis or liver cancer
[4]. Recently, World Health Organization (WHO) re-* Correspondence: drkhancemb@gmail.com
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reproduction in any medium, provided the orported that nearly 170 million people are chronically
infected with hepatitis C virus worldwide. In Asia-pacific
region, the prevalence of chronic hepatitis C ranges from
4% to 12% [5]. In Pakistan more than 10 million people
are suffering from HCV that comprise to 6% of total
population of Pakistan, with high morbidity and mortal-
ity [6]. In previous small studies HCV prevalence in
some other cities of Pakistan was reported high as well.
Like it was 16% in Lahore, 20.6% in Faisalabad and
23.8% in Gujranwala [7,8].
The HCV diagnosis is carried out by detecting the
presence of circulating anti-HCV antibodies using
Immunochromatographic test (ICT) methods; however
due the false positivity rate of HCV with ICT based
methods, Enzyme Linked Immunosorbant Assay (ELISA)
is considered more reliable than ICT based HCV diagno-
sis. Previously, a small scale study was conducted
reporting the prevalence of HCV genotypes in the generald. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Hepatitis C and B virus seroprevalence and coinfection
along with HIV in injecting drug users of Quetta region of
Balochistan [10]. However, a general screening study for
HCV infection in the young healthy male population of
the province was not yet reported. Therefore, the
present study was undertaken to find the prevalence of
HCV infection in the young males ranging from 17 to
25 years in Balochistan, Pakistan. Moreover, use of
an ICT (Immuno-chromatographic test) and ELISA
(Enzyme-Linked Immunosorbent Assay) coupled HCV
screening approaches were used to report the HCV
prevalence. These findings may be helpful to devise
strategy for the prevention of HCV associated risk
factors.Results
HCV prevalence among the young blood donors of
Quetta, Balochistan
A total of 356 blood samples were taken from healthy
young male blood donor population with mean age 21
(±4) years. Total numbers of samples in different age
groups are listed in Table 1. Of total 356 samples, 79
(22.2%) were positive for anti-HCV antibodies by ICT
method (Table 1). Furthermore, positive samples were
confirmed by ELISA. In the ICT positive samples 79
(22.2%), 74 (20.8%) samples were positive for anti-HCV
antibodies using ELISA method (Table 1).Discussion
Hepatitis C is a global health problem and every year up
to 170 million people become infected with HCV world-
wide with a mortality rate of more than 350,000 people
[5]. HCV has high prevalence in developing and also
high populated countries including Pakistan. Several fac-
tors contribute to increasing HCV prevalence such as
lack of awareness regarding HCV transmission, and pre-
cautionary measures among common people, inadequateTable 1 Frequency of HCV infection according to age groups










Total 356 79diagnostic facilities and expertise in hospitals and public
sector laboratories [3].
In recent years, many studies have been conducted to
investigate the prevalence of HCV in Pakistan [6,11]. As,
only a few (20-50%) of infected individuals clear the
virus spontaneously, while the majority of patients de-
velop chronic hepatitis that is why a high alarming fre-
quency of hepatitis c viral infection was seen in different
parts of the country, such as 20.6% in Faisalabad and
23.8% in Gujranwala [7,8]. Previously, a study was
conducted to determine the prevalence of HCV geno-
types in the general population of Balochistan province
of Pakistan [9]. Furthermore, Hepatitis C and B virus
seroprevalence and co-infections along with HIV in
injecting drug users of Quetta were also reported [10].
In the present study commonly practiced serological
techniques (ICT and ELISA) were employed to screen
out the prevalence of HCV in the young blood donors in
age group 17–25 years (Table 1). We found that overall
prevalence of HCV was 22.2% and 20.2% when tested by
ICT and ELISA based methods respectively. Interestingly
we observed that maximum prevalence (26.3%) for anti-
HCV was found in the individuals of 25 years old
(n = 38) (Table 1). Though our study provides no infor-
mation regarding HCV incidence in the general popula-
tion; however it does represent the HCV prevalence in
the young blood donors, which reflects a more specific
study. The highest burden of HCV in young individuals
were observed in Quetta region of Baluchistan using
ICT and ELISA based HCV diagnostics which are not
routinely done in other hospitals of Baloschistan. This
might be further evaluated in increased sample size, and
PCR based HCV diagnostics in young blood donors.
In general practice, it was consistently reported that
screening by ICT method may produce false positive
results, and is not recommended as a single diagnostic
tool for HCV detection [3,12]. To minimize the chances
of false positivity, we rechecked all the positive samples
checked by ICT method, were also subjected to screenamong the young blood donors of Quetta, Balochistan
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gest that considering ICT as diagnostic tool might be
misleading in some cases so critical care must be taken
in account before reporting the results. Our results indi-
cated that one sample each in the age group of 20, 21
and 25 years was false positive for anti-HCV. Moreover,
two samples in the age group of 24 years old were con-
firmed false positive on ELISA. Hence, the anti-HCV
prevalence dropped from 28.9% to 26.3% in the age
group 25 year old, from 26.5% to 24.5% in the age group
20 year old, from 20.4% to 18.5% in the age group of
21 year old and from 25.9% to 22.2% in a the age group
of 24 years old respectively.
Results of the present study show high HCV preva-
lence in the young population of Quetta region because
Pakistan still remains a high prone zone for HCV infec-
tion. In addition, Ahmed et al. 2007 and Aslam M et al.
2007 previously reported high HCV prevalence (up to
23.8%) in people of other parts of Pakistan. Furthermore,
the geographic location of Quetta (on border with
Afghanistan) and large influx of Afghan refugees con-
tribute also to high HCV infection. Poor health facilities
and infection control in public hospitals and lack of
healthcare-related awareness are some of the other risk
factors contributing to the high HCV prevalence in this
region. As the present study is comprised of less number
of participants who visited a hospital and were screened
positive for HCV. It might be possible that participants
of this study were infected already but they were not
gone through medical examination before this. Our data
also indicates that testing of blood and blood products
by ICT devices may not be used as a single reliable tool
for the anti-HCV prevalence, and may produce mislead-
ing findings. Interestingly, in Balochistan HCV screening
is usually performed with ICT method only, so we sug-
gest that ICT results should be reconfirmed by more so-
phisticated techniques such as ELISA and PCR in the
hospitals and in all health care units. Although, the
present study is not on large scale, but it will provide
the preliminary information regarding the prevalence of
HCV in the young blood donors of Quetta region of
Balochistan.Conclusion
The present study highlights the preliminary information
regarding the prevalence of HCV in the young popula-
tion of Quetta, Balochistan. Furthermore, screening of
HCV by ICT method seems less reliable and should be
reconfirmed with ELISA and PCR method on parallel to
improve the diagnostic tools for HCV in this region.
The need is that the government should address this
major health issue comprehensively by enhancing sur-
veillance, prevention, care, and treatment.Materials and methods
Study area and sample collection
Volunteer blood donors were included in this study
from different areas of Balochistan mainly from Quetta
and surrounding region. The study was conducted on
those volunteer who reporting during the study period
(January 2011 to April 2011) at the Combined Mili-
tary Hospital (CMH) Quetta, Balochistan, Pakistan. The
study was approved by the ethical committee of the Uni-
versity of Balochistan with reference number (EC/UOB/
0094). Blood samples were collected from a total of 356
healthy young volunteer blood donors with an age range
of 17–25 years upon their written consent. HCV screen-
ing was performed using ICT and ELISA based methods.
Immuno-chromatographic tests (ICT)
Blood samples were collected in EDTA-tubes. Serum
was isolated from blood samples for viral antibodies
detection. anti-HCV antibodies was detected by ICT as
described by manufacturers. For this purpose, immune-
chromatographic strips were obtained from two different
vendors including Accurate and Acon (Acon, USA).
Enzyme linked immunosorbant assay (ELISA)
Positive sera confirmed though ICT were tested for anti-
HCV antibodies by ELISA using Biokit, S.A, (Barcelona-
Spain) according to the manufacturer’s protocol.
Data analysis
The data was analyzed with Window 7, Microsoft Excel
2007 (Microsoft, USA). Hepatitis C incidence was calcu-
lated in different age groups in terms of percentages.
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